Cushing's Syndrome Recruiting Phase 3 Trials for Relacorilant (DB14976)

Also known as: Cushing Syndrome / Cushing’s syndrome / Cushings syndrome / Syndrome Cushing's

IndicationStatusPhase
DBCOND0028130 (Cushing's Syndrome)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03697109A Study of the Efficacy and Safety of Relacorilant in Patients With Endogenous Cushing SyndromeTreatment